tenk.fyi

Corvus Pharmaceuticals, Inc.

CRVSNasdaq· Pharmaceutical Preparations

Price History

Revenue

-

Net Income

-$15.3M

75.5% YoY

EPS

$-0.53

48.0% YoY

Cash

$4.6M

47.6% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.

Upgrade to Pro